| Role of RNA interference (RNAi) in dengue virus replication and identification of NS4B as an RNAi suppressor PK Kakumani, SS Ponia, V Sood, M Chinnappan, AC Banerjea, ... Journal of virology 87 (16), 8870-8883, 2013 | 238 | 2013 |
| Antibody-dependent enhancement: a challenge for developing a safe dengue vaccine R Shukla, V Ramasamy, RK Shanmugam, R Ahuja, N Khanna Frontiers in cellular and infection microbiology 10, 572681, 2020 | 168 | 2020 |
| A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which … V Ramasamy, U Arora, R Shukla, A Poddar, RK Shanmugam, LJ White, ... PLoS neglected tropical diseases 12 (1), e0006191, 2018 | 81 | 2018 |
| Bispidine-amino acid conjugates act as a novel scaffold for the design of antivirals that block Japanese encephalitis virus replication V Haridas, KS Rajgokul, S Sadanandan, T Agrawal, V Sharvani, ... PLoS neglected tropical diseases 7 (1), e2005, 2013 | 48 | 2013 |
| Dengue NS3, an RNAi suppressor, modulates the human miRNA pathways through its interacting partner PK Kakumani, KS Rajgokul, SS Ponia, I Kaur, S Mahanty, GR Medigeshi, ... Biochemical Journal 471 (1), 89-99, 2015 | 38 | 2015 |
| Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models R Shukla, H Beesetti, JA Brown, R Ahuja, V Ramasamy, RK Shanmugam, ... EBioMedicine 60, 2020 | 24 | 2020 |
| Pichia pastoris-expressed Zika virus envelope domain III on a virus-like particle platform: design, production and immunological evaluation RK Shanmugam, V Ramasamy, R Shukla, U Arora, S Swaminathan, ... Pathogens and disease 77 (3), ftz026, 2019 | 23 | 2019 |
| Cocculus hirsutus-Derived Phytopharmaceutical Drug Has Potent Anti-dengue Activity R Shukla, RK Rajpoot, A Poddar, R Ahuja, H Beesetti, RK Shanmugam, ... Frontiers in Microbiology 12, 746110, 2021 | 16 | 2021 |
| Zika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement R Shukla, RK Shanmugam, V Ramasamy, U Arora, G Batra, JA Acklin, ... EBioMedicine 54, 2020 | 13 | 2020 |
| Association of HADHA with human RNA silencing machinery PK Kakumani, RK Shanmugam, I Kaur, P Malhotra, SK Mukherjee, ... Biochemical and Biophysical Research Communications 466 (3), 481-485, 2015 | 11 | 2015 |
| Antibody-dependent enhancement: a challenge for developing a safe dengue vaccine. Front Cell Infect Microbiol 10: 572681 R Shukla, V Ramasamy, RK Shanmugam, R Ahuja, N Khanna | 6 | 2020 |
| Antibody-dependent enhancement: a challenge for developing a safe dengue vaccine. Front Cell Infect Microbiol. 2020; 10: 572681 R Shukla, V Ramasamy, RK Shanmugam, R Ahuja, N Khanna Epub 2020/11/17. https://doi. org/10.3389/fcimb. 2020.572681 PMID: 33194810, 2020 | 5 | 2020 |
| Interaction of dengue NS3 with human RNA silencing machinery through HSPA1A PK Kakumani, RK Shanmugam, M Chinnappan, I Kaur, AP Chopra, ... bioRxiv, 2020.06. 08.140590, 2020 | 1 | 2020 |
| Correction: Bispidine-Amino Acid Conjugates Act as a Novel Scaffold for the Design of Antivirals That Block Japanese Encephalitis Virus Replication V Haridas, KS Rajgokul, S Sadanandan, T Agrawal, V Sharvani, ... PLOS Neglected Tropical Diseases 18 (1), e0011917, 2024 | | 2024 |
| Zika Virus Envelope Nanoparticle Antibodies Protect Mice without Risk of Disease Enhancement (vol 54, 102738, 2020) R Shukla, RK Shanmugam, V Ramasamy, U Arora, G Batra, JA Acklin, ... EBIOMEDICINE 66, 2021 | | 2021 |
Sunil MukherjeeINSA-Sr Scientist; Plant Pathology, IARI在 icgeb.res.in 的电子邮件经过验证
